Received: 23 July 2020
Accepted: 5 February 2021
First Online: 17 February 2021
Ethics approval and consent to participate
: This trial has received favourable ethical approval from the Mater Misericordiae University Hospital Institutional Review Board (IRB) on the 10th December 2019. IRB Reference: 1/378/2088. Upon completion of this trial, the data will be presented at local and national level conferences and in peer-reviewed journals. We will inform the IRB (and trial registry) of any changes that are subsequently made to the protocol, as well as submitting a report of our progress including any adverse events that may occur to the IRB. All participants will be required to give signed informed consent to participate in this trial.
: Not applicable
: The authors declare no competing interests.